Clinical Trial Update: Alternatives for Reducing Chorea in Huntington Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating alternatives for reducing chorea in Huntington disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: Auspex Pharmaceuticals, Inc. | Conditions: Chorea Associated With Huntington Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-04-16